
zzso B virus zzso zzso has been described in cancer patients who received zzso therapy and may result in liver damage of varying degrees of zzso There is no known effective zzso zzso a zzso zzso has been found to suppress zzso replication and to improve zzso in chronic carriers of zzso B zzso The outcome of zzso therapy (at doses of 100 or 150 zzso in eight patients who developed zzso zzso while receiving zzso chemotherapy is zzso Each of the eight patients had zzso suppression of the zzso zzso DNA zzso Three of the five patients who were initially zzso positive underwent zzso Five patients had zzso of liver function tests and improvement in clinical zzso However, one patient died of zzso failure due to zzso zzso liver zzso and two died of widespread zzso (including zzso from the primary zzso It is concluded that early zzso zzso at the onset of zzso zzso before severe zzso zzso of zzso may be effective in the control of zzso zzso during zzso In Hong Kong, where zzso B infection is endemic, we propose to screen all cancer patients for zzso B surface zzso before zzso therapy, and to closely monitor liver function of those who are found to be zzso zzso 

